Regulus Therapeutics Inc.
- UEI
- G91LF6QLP323
- CAGE
- 5M2K0
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- novartis.com
- Founded
- 1996
- Employees
- 100K+
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Niaid sbir PHS 2020-1 topic 084: "antiviral drugs to cure chronic hepatitis b virus infection" | National Institute of Allergy and Infectious Diseases | $300,000 |
Quick answers
What is Regulus Therapeutics Inc.'s UEI?
Regulus Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is G91LF6QLP323.
What is Regulus Therapeutics Inc.'s CAGE code?
Regulus Therapeutics Inc.'s CAGE code is 5M2K0.
What is Regulus Therapeutics Inc.'s primary NAICS code?
Regulus Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Is Regulus Therapeutics Inc. registered in SAM.gov?
Regulus Therapeutics Inc.'s SAM.gov registration expired on March 5, 2024.
What is Regulus Therapeutics Inc.'s most recent federal award?
Regulus Therapeutics Inc.'s most recent federal contract award is Niaid sbir PHS 2020-1 topic 084: "antiviral drugs to cure chronic hepatitis b virus infection" (75N93020C00046), from National Institute of Allergy and Infectious Diseases, on August 21, 2020.
On GovTribe
See Regulus Therapeutics Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors